Navigation Links
Nervous culprit found for Tassie devil facial tumor disease
Date:12/31/2009

Cells that protect nerves are the likely origin of the Devil Facial Tumour Disease (DFTD) that has been devastating Australia's Tasmanian devil population, an international team of scientists has discovered.

Devil Facial Tumour Disease (DFTD) is a transmissible cancer that affects only Tasmanian devils and was first reported in 1996. It is spread by biting and quickly kills the animals. The disease is characterised by large tumours, mostly on the face and mouth, which often spread to internal organs.

The research collaboration, led by Australian scientists, has found that DFTD originates from cells called Schwann cells, which protect peripheral nerve fibres.

The results have been published today in the international journal Science.

Through the discovery, the team has now identified a genetic marker that could be used to accurately diagnose the perplexing cancer, which has seen the devil listed as endangered and facing extinction.

Lead author Dr Elizabeth Murchison from the Australian National University said the Schwann cell discovery was significant as there are currently no specific diagnostic tests, treatments or vaccines available for the disease.

"We took biopsies from devil tumours and extracted genetic data from them," Dr Murchison said.

Dr Tony Papenfuss from Melbourne's Walter and Eliza Hall Institute then led the team that determined which genes were switched on in the tumours and identified their genetic signature.

"When we compared the signature of the tumours to other normal tissues we found the tumours were most like Schwann cells," Dr Papenfuss said.

Associate Professor Greg Woods from the University of Tasmania's Menzies Research Institute said the Schwann cell find was an important step in the process to further understand the disease.

"Devils develop tumours of all different types and the genetic markers we have identified are useful for telling apart the tumours that occur in DFTD from other kinds of tumours," Associate Professor Woods said.

The Schwann cell research was conducted as part of the Save the Tasmanian Devil Program's efforts to further explore DFTD. It was supported by the National Health and Medical Research Council and the University of Tasmania's Dr Eric Guiler Tasmanian Devil Research Grant.


'/>"/>

Contact: Penny Fannin
fannin@wehi.edu.au
61-417-125-700
Walter and Eliza Hall Institute
Source:Eurekalert  

Related biology news :

1. Obesity and the central nervous system -- the state of the art
2. Rutgers scientists research reveals critical knowledge about the nervous system
3. Building the future -- 21st century nano tools to repair the nervous system
4. Queens study connects obesity with nervous system
5. Trainor Lab characterizes gene essential for prenatal development of nervous system
6. Researchers disprove 15-year-old theory about the nervous system
7. Development of an artificial simulator of the nervous system to do research into diseases
8. Worth a thousand words: Hopkins researchers paint picture of cancer-promoting culprit
9. Apple or pear shape is not main culprit to heart woes -- its liver fat
10. Key to out-of-control immune response in lung injury found
11. Natural chemical found in broccoli helps combat skin blistering disease
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Nervous culprit found for Tassie devil facial tumor disease
(Date:6/23/2017)... ITHACA, N.Y. , June 23, 2017  IBM ... in dairy research, today announced a new collaboration using ... the chances that the global milk supply is impacted ... project, Cornell University has become the newest academic institution ... Chain, a food safety initiative that includes IBM Research, ...
(Date:5/23/2017)... , May 23, 2017  Hunova, the first robotic gym for ... has been officially launched in Genoa, Italy . The ... and the USA . The technology was ... the market by the IIT spin-off Movendo Technology thanks to a 10 ... Multimedia News Release, please click: ...
(Date:5/16/2017)... 16, 2017   Bridge Patient Portal , ... MD EMR Systems , an electronic medical ... GE, have established a partnership to build an ... the GE Centricity™ products, including Centricity Practice Solution ... These new integrations will allow healthcare delivery ...
Breaking Biology News(10 mins):
(Date:9/21/2017)... London UK (PRWEB) , ... September 21, 2017 ... ... , a QuintilesIMS company, who enable the world’s most progressive pharma and biotech ... 2,000 clinical trials at top pharma and biotech events in Q4. , DrugDev ...
(Date:9/21/2017)... ... September 21, 2017 , ... When a downtown ... response was swift and efficient thanks to the continuing efforts of members of ... of more than 50 stakeholders, including officials from area counties and cities, Renewable ...
(Date:9/21/2017)... ... September 21, 2017 , ... Biorez, ... election of Paul Hermes, Entrepreneur in Residence at Medtronic, Inc., to serve as ... a proprietary, tissue-engineered scaffold for anterior cruciate ligament (ACL) reconstruction that is designed ...
(Date:9/20/2017)... ... September 20, 2017 , ... Cybrexa Therapeutics , ... to the role of chief scientific officer. In this role, Dr. Paralkar will ... president and CEO, Per Hellsund. , “I was impressed with Cybrexa’s revolutionary technology ...
Breaking Biology Technology: